These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3427223)

  • 1. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast.
    Hansen R; Quebbeman E; Beatty P; Ritch P; Anderson T; Jenkins D; Frick J; Ausman R
    Breast Cancer Res Treat; 1987 Nov; 10(2):145-9. PubMed ID: 3427223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer.
    Hansen R; Moynihan T; Beatty P; Quebbeman E; Libnoch J; Schulte W; Anderson T
    Urology; 1991 Apr; 37(4):358-61. PubMed ID: 2014602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study.
    Hansen R; Quebbeman E; Ritch P; Chitambar C; Anderson T
    Am J Med Sci; 1988 Feb; 295(2):91-3. PubMed ID: 3344760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer.
    Regazzoni S; Pesce G; Marini G; Cavalli F; Goldhirsch A
    Ann Oncol; 1996 Oct; 7(8):807-13. PubMed ID: 8922194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous 5-fluorouracil infusion in advanced gastric carcinoma.
    Moynihan T; Hansen R; Anderson T; Quebbeman E; Beatty P; Ausman R; Ritch P; Chitambar C; Vukelich M
    Am J Clin Oncol; 1988 Aug; 11(4):461-4. PubMed ID: 3407626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous intravenous infusion of 5-fluorouracil in the treatment of refractory breast cancer.
    Chang AY; Most C; Pandya KJ
    Am J Clin Oncol; 1989 Oct; 12(5):453-5. PubMed ID: 2801607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: results in 91 patients.
    Hansen R; Quebbeman E; Ausman R; Frick J; Ritch P; Schulte W; Haas C; Beatty P; Anderson T
    J Surg Oncol; 1989 Mar; 40(3):177-81. PubMed ID: 2645464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
    Gebbia V; Borsellino N; Testa A; Tirrito M; Varvara F; Cucchiara A; Mauceri G; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(4C):3553-7. PubMed ID: 10629652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer.
    Jabboury K; Holmes FA; Hortobagyi G
    Cancer; 1989 Aug; 64(4):793-7. PubMed ID: 2743272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
    Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
    Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer.
    Leichman CG; Leichman L; Spears CP; Rosen PJ; Jeffers S; Groshen S
    J Natl Cancer Inst; 1993 Jan; 85(1):41-4. PubMed ID: 8416255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
    Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
    J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
    Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
    Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial of continuous infusion of 5-fluorouracil using an ambulatory pump for metastatic colorectal cancer.
    Yamao T; Shimada Y; Kondo H; Shirao K; Yokota T; Sugano K; Saito D; Ohkura H; Yoshida S
    Jpn J Clin Oncol; 1995 Apr; 25(2):46-50. PubMed ID: 7745822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
    Ardalan B; Sridhar KS; Benedetto P; Richman S; Waldman S; Morrell L; Feun L; Savaraj N; Fodor M; Livingstone A
    Cancer; 1991 Sep; 68(6):1242-6. PubMed ID: 1873776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion 5-fluorouracil as salvage chemotherapy in patients with advanced colorectal cancer.
    Lim WT; Koo WH; Au E; Khoo KS
    Ann Acad Med Singap; 1999 Mar; 28(2):256-9. PubMed ID: 10497678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.